Bionex Pharmaceuticals
Bionex Pharmaceuticals LLC is a privately held pharmaceutical development company specializing in topical, transdermal/transmucosal, and implant drug delivery systems, offering CRMO services in formulation, testing, and clinical supply manufacturing to pharmaceutical and biotechnology clients.
- Company typePrivate
- Founded2007
- HeadquartersNorth Brunswick, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Bionex Pharmaceuticals firmographics
Firmographics- Name
- Bionex Pharmaceuticals
- Legal name
- Bionex Pharmaceuticals LLC
- Website
- https://bionexpharma.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Bionex Pharmaceuticals LLC is a privately held pharmaceutical development company specializing in topical, transdermal/transmucosal, and implant drug delivery systems, offering CRMO services in formulation, testing, and clinical supply manufacturing to pharmaceutical and biotechnology clients.
- Ownership category
- akta.pro rank
Bionex Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Contract Development & Manufacturing (CRMO/CDMO)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Scientific Research and Development Services (5417), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industries
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where Bionex Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- North Brunswick
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bionex Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- CRMO Services: Contract Research Manufacturing Organization services providing drug formulation development, product performance testing, and manufacturing of clinical supplies. Revenue generated through service contracts with pharmaceutical and biotechnology companies.
- Drug Delivery Technology Licensing: Development and potential licensing of proprietary drug delivery systems and technologies to pharmaceutical partners
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Bionex Pharmaceuticals product offering
Product offeringCore offering
Bionex Pharmaceuticals is a pharmaceutical development company that develops proprietary novel drug delivery systems (topical, transdermal/transmucosal, and implant formulations) and provides full-spectrum CRMO (Contract Research Manufacturing Organization) services including drug formulation development, product performance testing, pre-formulation and dosage form design, analytical chemistry integration, product stability studies, clinical supply manufacturing, process development/optimization, IND-CMC package preparation, and quality system, tech transfer, regulatory, and patent filing support. The company also licenses its drug delivery technology platforms to pharmaceutical partners and collaborates with NIH, NSF, state grant programs, and non-profit organizations on funded innovation R&D projects.
Differentiator
Problem solved
Functional benefit
Products and services
- CRMO Services (Contract Research Manufacturing Organization) Comprehensive contract research and manufacturing services for pharmaceutical and biotechnology clients, including drug formulation development, product performance testing, pre-formulation and dosage form design, product innovation and life-cycle management, integration with analytical chemistry and product stability studies, clinical supply manufacturing, process development and optimization, IND-CMC package readiness and submission, and full support for quality system, tech transfer, regulatory, and patent filings.
- Pre-formulation and Dosage Form Design Standalone early-stage formulation development service delivering pre-formulation studies and dosage form design for client pharmaceutical programs, intended for pharma and biotech teams building novel drug products.
- Product Innovation and Life-Cycle Management Service offering product innovation and life-cycle management for pharmaceutical products, supporting clients in extending product value through reformulation, new dosage forms, or expanded indications via Bionex's drug delivery expertise.
- Clinical Supply Manufacturing and Process Optimization Clinical supply manufacturing service including process development and optimization, designed for pharmaceutical and biotechnology clients requiring clinical-stage material production in support of human studies.
- IND-CMC Package Readiness and Submission Support Service providing IND-CMC (Chemistry, Manufacturing and Controls) package preparation and submission support for regulatory compliance, aimed at pharmaceutical and biotech clients preparing Investigational New Drug applications.
- Drug Delivery Technology Licensing (Topical, Transdermal/Transmucosal, Implant Platforms) Licensing offering that makes Bionex's proprietary topical, transdermal/transmucosal, and implant drug delivery platforms available to pharmaceutical partners for use with their own pipeline assets, typically paired with co-development engagements.
Companies that use Bionex Pharmaceuticals
Customer profileSegments2 records
Ideal customer profiles2 records
Bionex Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Bionex Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Co-development PartnerscoreBionex actively seeks co-development partnerships with pharmaceutical and biotechnology companies to jointly develop innovative drug delivery systems and technologies. The company is seeking partners to expand its portfolio of collaborative development initiatives.
Scale indicators1 record
Bionex Pharmaceuticals competitors and assessment
Company assessmentMarket position
Customer concentration
Bionex Pharmaceuticals social profiles
Digital presenceBionex Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bionex Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
Bionex Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bionex Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bionex Pharmaceuticals
What does Bionex Pharmaceuticals do?
Bionex Pharmaceuticals is a pharmaceutical development company that develops proprietary novel drug delivery systems (topical, transdermal/transmucosal, and implant formulations) and provides full-spectrum CRMO (Contract Research Manufacturing Organization) services including drug formulation development, product performance testing, pre-formulation and dosage form design, analytical chemistry integration, product stability studies, clinical supply manufacturing, process development/optimization, IND-CMC package preparation, and quality system, tech transfer, regulatory, and patent filing support. The company also licenses its drug delivery technology platforms to pharmaceutical partners and collaborates with NIH, NSF, state grant programs, and non-profit organizations on funded innovation R&D projects.
Is Bionex Pharmaceuticals a public or private company?
Bionex Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bionex Pharmaceuticals founded?
Bionex Pharmaceuticals was founded in 2007. It employs 1 to 10 people.
Where is Bionex Pharmaceuticals based?
Bionex Pharmaceuticals is headquartered in North Brunswick, United States, in the North America region.
How does Bionex Pharmaceuticals make money?
Two revenue lines are on record. CRMO Services are the primary driver. The others are drug Delivery Technology Licensing.
Does Bionex Pharmaceuticals have an API?
No public API is recorded for Bionex Pharmaceuticals.
What industry is Bionex Pharmaceuticals in?
Bionex Pharmaceuticals's product category is Pharmaceutical Contract Development & Manufacturing (CRMO/CDMO). Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 325412 and its SIC code is 2834.